Journal of Global Pharma Technology

Size: px
Start display at page:

Download "Journal of Global Pharma Technology"

Transcription

1 ISSN Journal of Global Pharma Technology Available Online at Research Paper The Degree of Agreement between Manual and Digital Histological Evaluation of Immunohistochemical Expression of Estrogen and Progesterone Receptors in Breast Carcinoma Hameda Abd-Al Mahdi Ghazi College of medicine, University of Babylon- Hilla-Iraq. Abstract Background Malignant neoplasm involving the breast is by far one of the most frequent cancers that affect mankind. Globally, it is estimated that breast cancer accounts for about 25% of all cancers affecting women. Carcinoma of the breast is heterogeneous; however, they all share the common origin from the terminal duct lobular unit. They are generally classified into ducal and lobular. The three gold standard immunohistochemical makers, nowadays, are progesterone and estrogen receptors (PR and ER) and her2neu. Other markers like p53 and bcle2 expression are also important. The study of PR and ER receptors permits the decision of adding and adjunct mode of treatment, hormonal treatment. Aim of the study the objective of this study was to assess automated digital study of immunohistochemical markers as a substitute for the original manual method. Materials and methods: The present study included 35paraffin embedded, formalin fixed histological blocks of breast carcinoma. The duration of the study extended from January 2017 to June 2017 and was conducted in the teaching laboratories of College of Medicine, Al-Qadissiyah Univerist, Al-Diwaniayah province, Iraq. The paraffin blocks were retrieved from the teaching laboratories of Al-Diwaniyah teaching hospital, Al-Diwaniayah province, Iraq. Results: Following conversion into positive and negative cases, matching was assessed using kappa agreement statistic and the results were as following: number of positive ER cases were 14 and 16 according to manual and digital scoring, respectively; whereas the number of positive PR cases were 15 and 17 according to manual and digital scoring, respectively, as shown in table 3 and 4. The degree of agreement between manual and digital scoring was 0.87, considered good, in both ER and PR expression status. Conclusion Digital scoring appears to be faster than and as accurate as manual scoring; however it needs to be correlated with clinical prognosis of breast carcinoma. Introduction Malignant neoplasm involving the breast is by far one of the most frequent cancers that affect mankind. Globally, it is estimated that breast cancer accounts for about 25% of all cancers affecting women. Although, it is well known disease in women, it can affect men; nevertheless, its incidence in male patients is less than 1: 100 when compared to female patients [1]. According to [2] 2014, breast cancer in Iraqi women ranks the first among other forms of cancers and accounts for about 33.8%. Anatomically speaking, the breast or mammary glands are specialized accessory glands that are located in the pectoral region and present in both sexes; however, they are strictly functional in women and secrete milk. The breast harbors fifteen to twenty five lactiferous ductss that start at the nipples then divide into smaller ducts and terminates in the terminal ductt lobular unite (lobule) that is formed of a terminal duct and a number of small acini. The ducts and ductless are lined by a layer of cubical to columnar epithelial cells and an external my epithelial cell layer. The connective tissue within the lobule is made up of fibroblasts in a matrix of collagen and acid mucins, together with histiocytes and little number of lymphocytes. The interlobular stroma is hypocellularr and formed of fibroadipose tissue. The lining epithelium and the stroma are responsive to hormones. Throughout pregnancy there is a pronounced proliferation of acini, leading to enlargement of lobules, and the epithelial cells possess abundant cytoplasm rich in secretary vacuoles [3] , JGPT. All Rights Reserved 201

2 Neoplasms are uncontrolled cellular proliferation that affect body tissues and result in districted structure and function. Neoplasms affecting breast tissue are diverse and can originate from epithelium, connective tissues, lymphoid cells, vascular tissue and melanocytes. Tumors originating from epithelial tissues are by far the most common and usually present in the form of adenoma or carcinoma. The most common benign breast tumor is fibro adenoma, whereas the most frequent malignant breast tumor is carcinoma [4]. Carcinoma of the breast is heterogeneous; however, they all share the common origin from the terminal duct lobular unit. They are generally classified into ductal and lobular. Ductal carcinoma are characterized by formation of duct like structures with stromal invasion, while, lobular type is characterized by acinar formation and single cell infiltration of the stroma. Further classification is determined by the presence or nascence of basement membrane breaching and stromal invasion by malignant cells [5]. The general scheme will be in the form of one the following major groups: insituductall carcinoma, invasiveductall carcinoma, insituu lobularr carcinoma, invasive lobular carcinoma. Invasive ductal carcinoma is further sub-classified into: tubular, papillary, come do, medullar and mutinous according to specific morphologic features, however, invasive ductal carcinoma of no special type or in other words not otherwise specified (NOS) is by far the most frequent and accounts for about 75-80% [6]. Management of carcinoma of breast is dependent up on the stage and grade of the disease and other characteristics. Stage means the degree of spread of the lesion while grade means the degree of differentiation or resemblance of the malignant lesion to the original breast tissue. Surgical removal is the standard way of treatment together with chemotherapy and or radiotherapy [7]. Another important determinant of the way of treatment is the expression of immunohistochemical markers. The three gold stand ardimmunohistochemical makers, nowadays, are progesterone and estrogen receptors (PR and ER) and her2neu [8]. Other markers like p 53 and bcle 2 expression are also important. The study of ER and PR receptors permits the decision of adding and adjunct mode of treatment, hormonal treatment. The study of these two immmunohistochemical markers, is nowadays, totally manual and subjective and great inter-observer and intra-observer variations exist. So the objective of this study was to assess automated digital study of immunohistochemical markers as a substitute for the original manual method [8]. Materials and Methods The present study included 35 paraffin embedded, formalin fixed histological blocks of breast carcinoma. The duration of the study extended from January 2017 to June 2017 and was conducted in the teaching laboratories of College of Medicine, Al- Qadissiyah Univerist, Al-Diwaniayah province, Iraq. The paraffin clocks were retrieved from the teaching laboratories of Al-Diwaniyah teaching hospital, Al- Diwaniayah province, Iraq. The first step was to review the biopsy reports available at the laboratories from January 2015 through the present time of the study in order to get the most recent convenient sample of paraffin blocks belonging to patients already diagnosed with breast carcinoma. Next, from each paraffin block, thin sections (5 μm widths) were prepared, 3 in number: one for revaluation of H and E stained sections and two for immunohistochemical staining with ER and PR markers. Standard immunostaining was carried out according to the providing company and included the following steps: deparafinization and attaching tissues to positively charged slides followed by antigen retrieval and addition of the primary antibody after pap pen labeling and then incubation at 37 C for 30 minutes. The next step involved the addition of the conjugated secondary antibody and then the addition of avid in horse radish peroxides complex and then the addition of the chromogen substrate. Each step was followed by proper washing using standard washing solution. The results of staining procedures are shown in figures (1and 2) , JGPT. All Rights Reserved 202

3 Manual reading was carried out by two blinded pathologist using Olympus light microscope. Nuclearr staining was assessed for ER and PR. A score for the proportion of stained cells (zero = no nuclear staining, one = <1percent nuclear staining, two = 1-10percent nuclear staining, three = 11-33percent nuclear staining, four = 34-66percent nuclear staining and five = percent nuclear staining) and the intensity of staining (0 = no staining, 1 = weak staining, 2 = moderate staining, 3 = strong staining) were assigned to each tumor. The score for the proportion of cells stained and the score for the intensity of staining were added to get the total score, which ranged from 0 to 8, A score of 0-2 was regarded as negative while 3-8 as positive. [9].Digital studying was done using Scan scope Leika (Germany) fully automated system Digital scoring was made to correspond to manual scoring so that we depend on two parameters, the proportion of cellss stained and intensity of color. The results were then transferred into Microsoft Excel sheet for further analysis. Data were statistically analyzed using SPSS. version 22. Mann Whitney U tool was utilized to compare mean scores, whereas, Chi-square was used to evaluate ratios. P- value was considered significant at a point equal to or less than Results The results of manual quick score are shown in table 1 and 2. Regarding estrogen receptor (ER) immunohistochemical staining score the following results were obtained: the number of cases were 16, 1, 0, 4, 4, 2, 2, 1 and 1 for as retrieved from rater 1 reports; the number of cases were 15, 2, 1, 3, 4, 2, 2, 1 and 1 for as retrieved from rater 2 reports. Regarding progesterone receptor (PR) immunohistochemical staining score the following results were obtained: the number of cases were 14, 2, 0, 0, 4, 3, 4, 3 and 1 for as retrieved from rater 1 reports; the number of cases were 13, 3, 0, 1, 3, 4, 3, 2 and 2 for as retrieved from rater 2 reports. Table 1: results of manual scoring for ER immunohistochemical expression ER PR Score Rater 1 Rater 2 Rater 1 Rater (51.6) 15 (48.4) 14 (45.2) 13(41.9) 1 1 (3.2) 2 (6.5) 2(6.5) 3(9.7) 2 0 (0.0) 1 (3.2) 0(0.0) 0(0.0) 3 4 (12.9) 3 (9.7) 0(0.0) 1(3.2) 4 4 (12.9) 4 (12.9) 4(12.9) 3(9.7) 5 2 (6.5) 2 (6.5) 3(9.7) 4(12.9) 6 2 (6.5) 2 (6.5) 4(12.9) 3(9.7) 7 1 (3.2) 1 (3.2) 3(9.7) 2(6.5) 8 1 (3.2) 1 (3.2) 1(3.2) 2(6.5) ER: estrogen receptors; PR: progesterone receptors Results of digital scoring are shown in table 2 and they were as following: the number of cases, concerning ER status, were 14, 1, 0, 4, 4, 2, 2, 2 and 2 for scores 0, 1, 2, 3, 4, 5, 6, 7 and 8, respectively. In PR status, the number of cases were 13, 1, 0, 0, 4, 3, 4, 4 and 2 for scores 0, 1, 2, 3, 4, 5, 6, 7 and 8, respectively. Table 2: results of digital scoring for ER immunohistochemical expression Score ER PR 0 14 (45.2) 13 (41.9) 1 1 (3.2) 1 (3.2) 2 0 (0.0) 0(0.0) 3 4 (12.9) 0(0.0) 4 4 (12.9) 4(12.9) 5 2 (6.5) 3(9.7) 6 2 (6.5) 4(12.9) 7 2 (6.5) 4 (12.9) 8 2 (6.5) 2 (6.5) ER: estrogen receptors; PR: progesterone receptors , JGPT. All Rights Reserved 203

4 Following conversion into positive and negative cases, matching was assessed using kappa agreement statistic and the results were as following: number of positive ER cases were 14 and 16 according to manual and digital scoring, respectively; whereas the number of positive PR cases were 15 and 17 according to manual and digital scoring, respectively, as shown in table 3 and 4. The degree of agreement between manual and digital scoring was 0.87, considered good, in both ER and PR expression status. Table 3: Rate of positive ER cases according to manual and digital scoring Kappa =0.87 Manual scoring Positive Negative Total Positive Digital scoring Negative Total Table 4: Rate of positive PR cases according to manual and digital scoring Kappa = 0.87 Manual scoring Positive Negative Total Positive Digital scoring Negative Total A B C D Figure 1: Immunohistochemical expression of estrogen receptors (ER) in breast carcinoma. A: Technical negative control. B: Negative. C: weak positive. D: Strong positive A B C D Figure 2: Immunohistochemical expression of progesterone receptors (PR) in breast carcinoma. A: Technical negative control. B: Negative. C: weak positive. D: Strong positive , JGPT. All Rights Reserved 204

5 Discussion Although, the estimation of malignant cell estrogen receptor (ER) expression status by immunohistochemical method has gained routine practice, the reproducibility of the assay has not been measured sufficiently. The issue of inter laboratory mismatch in the immunohistochemicall estimation of estrogen receptor status using a breast cancer tissue has been raised and investigated by Parker et al [10]. Their work involved a breast tumor tissue microarray, and they examined inter laboratory mismatch in ER reading. A 2-fold tissue microarray block was synthesized from twenty nine malignant breast blocks. Unstained slides were distributed to 5 laboratories and each laboratory immunostained and scored 1 slide for ER. Agreement among laboratories ranged from moderate to high (overall. kappa = 0.54 for zero-three+ grading; overall. kappa = 0.84 for negative vs positive assessment of ER status). When 1 observer scored each of the 5 slides, inter laboratory agreement was slightly better (kappa = 0.63 for 0-3+ scoring; kappa = 0.96 for positive versus negative scoring). When looking to the work of Parker et al., one can conclude that although the experiment used tissue microarray, the level of concordance was not always excellent among different labs and observers. In our opinion, the use of well-equipped and optimally standardized fully automated digital method in assessing immunohistochemical status of ER and PR may not result in such wide range of disagreement among different labs. The progesteron receptor and estrogen receptor status of human breast malignancy is regarded as an important marker from prognostic and predictive points of view of human breast cancer that affect therapeutic measures but their subjective way of interpretation result in intra observer, interaserver and fatigue variability. Inter observer agreement for estrogen receptor immunohistochemical analysis in breast cancer was also assessed by Diaz et al.[11]. In this study a series of seventy consecutive invasive breast malignant tumors, ER was determined using two methods: manual stating method and digital method. The comparison between manual and digital methods in the study of Diaz et al [11] reveled strong agreement (kappa =0.84); this results supports our findings and also they described high level of inter observer agreement related to manual method; also in agreement with the results of our study. Probably the availability of well-trained expert lab workers in the study performed by Diaz et al. and us is the cause behind good level of inter observer agreement and this may not always available and perhaps the use of digital scoring may reduce the need for well-trained lab workers and that minimal manipulation for well-established digital machine may give excellent results. Prasad et al. [12] carry out a comparison of manual and digital assessment immunostaining of 60 breast cancer tissue specimens. They performed comparison among three labs regarding manual method as well comparison of manual with digital scoring. The level of correlation between two pathologist was 0.46 and 0.66 for two pathologist regarding ER and PR expression respectively. This low level of correlation, in the study of Prasad et al., clearly demonstrated the effect of subjectivity of the manual determination of PR and ER status in breast carcinoma. The results of the present showed that digital scoring is characterized by overestimation of positive cases, ER and PR, when compared to manual scoring. This overestimation may be the direct results of variation in intensity measurement between manual and digital methods; however, the kappa agreement statistics gave a good result of A lower level of agreement was recorded by Hwatet al., in [13] when measuring the expression of ER in breast cancer both manually and digitally, and the level was (kappa =0.76). Similar rate of agreement was reported by Krecsáket al., in [14] of about 86% for both ER and PR. The overestimation of positive results, together with less than 100% agreement may raise the question of which method is more accurate in defining ER and PR status for breast carcinoma. For answering such a question, one should perform a large cohort study to relate overall survival with digital and manual scoring. Unfortunately this aim is out of scope of our study; nevertheless, such study was carried out by Stålhammar et al. [15] and stated that the digital scoring system was in major , JGPT. All Rights Reserved 205

6 aspects a better alternative to manual marker scoring and has the advantage to minimize time consumption for doctors, as many of the steps in the technique are either automatic or easy to manage without pathological expertise. The issue of time consumption and inter observer variability of manual method was raised by Vijayashree et al.[16] and they measured time needed to accomplish manual work in comparison with digital work and concluded that unlike routine manual techniques that are time consuming, a single run of digital way takes only a few minutes. When time is spent by pathologist to read a single slide of ER immunohistochemistry of breast tissue is equal to the same time needed to carry out examination of several H and E slides to assess histological diagnosis, References 1. Makki J (2015) Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance. Clinical Medicine Insights Pathology.8: Al-Hashimi MM, Wang XJ (2014) Breast cancer in Iraq, incidence trends from Asian Pac J Cancer Prev.15: Standring S, Gray H (2015) Gray's anatomy: The anatomical basis of clinical practice. Fortieth edition. Edinburgh: Churchill Livingstone/Elsevier Shah R, Rosso K, Nathanson SD (2014) Pathogenesis, prevention, diagnosis and treatment of breast cancer.world Journal of Clinical Oncology.5(3): Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK (2010) Various Types and Management Of Breast Cancer: An Overview. Journal of Advanced Pharmaceutical Technology & Research. 1(2): Sinn H-P, Kreipe H A (2013) Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. Breast Care. 8(2): Zhang BN, Cao XC, Chen JY (2012) et al Guidelines on the diagnosis and treatment of breast cancer (2011 edition).gland Surgery.1 (1): Mouttet D, Laé M, Caly M (2016) et al Estrogen- Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and Map Quant TM Microarray Based Assay. Sapino A, ed. PLoS ONE. 11(2):e Mudduwa LK (2009) Quick score of hormone receptor status of breast carcinoma: correlation with other clinicopathological prognostic parameters. Indian J PatholMicrobiol.52: this will of course make digital scoring superior to manual scoring of ER and PR status. It should be mentioned that scoring 31 cases for ER and PR status manually, took 2 weeks in order to be accomplished, whereas, it was carried out at a single run in one day for the digital procedure. This time consumption by manual method is coasty and can be reduced significantly by the use of digital method. Also there, was some inter-observer variation between rater 1 and 2, though it was minimal, but expert pathologist is always needed to perform such tedious work. In conclusion, digital scoring appears to be faster than and as accurate as manual scoring, however it needs to be correlated with clinical prognosis of breast carcinoma. 10. Parker RL, Huntsman DG, Lesack DW (2002) et al Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J ClinPathol. 117(5): Diaz LK, Sahin A, Sneige N (2004) Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: a comparison of manual and computer-assisted scoring methods. Ann DiagnPathol. 8 (1): Prasad K, Tiwari A, Ilanthodi S, Prabhu G, Pai M (2011) Automation of immunohistochemical evaluation in breast cancer using image analysis. World Journal of Clinical Oncology. 2(4): Howat WJ, Blows FM, Provenzano E (2015) et al Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. The Journal of Pathology: Clinical Research. 1(1): Krecsák L, Micsik T, Kiszler G (2011) et al Technical note on the validation of a semiautomated image analysis software application for estrogen and progesterone receptor detection in breast cancer. Diagnostic Pathology Stålhammar G (2016) et al Digital image analysis outperforms manual biomarker assessment in breast cancer. Mod. Pathol.doi: /modpathol Vijayashree R, Aruthra P, Rao KR (2015) A Comparison of Manual and Automated Methods of Quantitation of Oestrogen/Progesterone Receptor Expression in Breast Carcinoma. Journal of Clinical and Diagnostic Research : JCDR. 9 (3):EC01-EC , JGPT. All Rights Reserved 206

Breast Pathology. Breast Development

Breast Pathology. Breast Development Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th

More information

BREAST PATHOLOGY. Fibrocystic Changes

BREAST PATHOLOGY. Fibrocystic Changes BREAST PATHOLOGY Lesions of the breast are very common, and they present as palpable, sometimes painful, nodules or masses. Most of these lesions are benign. Breast cancer is the 2 nd most common cause

More information

1 NORMAL HISTOLOGY AND METAPLASIAS

1 NORMAL HISTOLOGY AND METAPLASIAS 1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous

More information

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Mona A. Abd-Elazeem, Marwa A. Abd- Elazeem Pathology department, Faculty of Medicine, Tanta

More information

Breast pathology. 2nd Department of Pathology Semmelweis University

Breast pathology. 2nd Department of Pathology Semmelweis University Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/

More information

Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers

Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers Breast Cancer Vol. 14 No. 1 January 2007 Original Article Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers

More information

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR BREAST LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR HISTOLOGY LOBE: (10 in whole breast) LOBULE: (many per lobe) ACINUS/I, aka ALVEOLUS/I: (many per lobule) DUCT(S): INTRA- or

More information

Your Guide to the Breast Cancer Pathology. Report. Key Questions. Here are important questions to be sure you understand, with your doctor s help:

Your Guide to the Breast Cancer Pathology. Report. Key Questions. Here are important questions to be sure you understand, with your doctor s help: Your Guide to the Breast Cancer Pathology Report Key Questions Here are important questions to be sure you understand, with your doctor s help: Your Guide to the Breast Cancer Pathology Report 1. Is this

More information

Her-2/neu expression and its correlation with ER status and various clinicopathological parameters

Her-2/neu expression and its correlation with ER status and various clinicopathological parameters Original Research Article DOI: 10.5958/2394-6792.2016.00106.X Her-2/neu expression and its correlation with ER status and various clinicopathological parameters Kriti Chauhan 1,*, Monika Garg 2, Abhimanyu

More information

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following

More information

Mousa. Israa Ayed. Abdullah AlZibdeh. 0 P a g e

Mousa. Israa Ayed. Abdullah AlZibdeh. 0 P a g e 1 Mousa Israa Ayed Abdullah AlZibdeh 0 P a g e Breast pathology The basic histological units of the breast are called lobules, which are composed of glandular epithelial cells (luminal cells) resting on

More information

Research Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67

Research Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67 SAGE-Hindawi Access to Research International Breast Cancer Volume 20, Article ID 47957, 4 pages doi:0.406/20/47957 Research Article Stromal Expression of CD0 in Invasive Breast Carcinoma and Its Correlation

More information

Diseases of the breast (2 of 2) Breast cancer

Diseases of the breast (2 of 2) Breast cancer Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at

More information

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,

More information

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa. Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,

More information

Basement membrane in lobule.

Basement membrane in lobule. Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.

More information

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue Page 1 The need for multiplex detection of tissue biomarkers. There is a constant and growing demand for increased biomarker analysis in human tissue specimens. Analysis of tissue biomarkers is key to

More information

Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology

Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology Ugur Ozerdem, M.D. 1 Abstract Background: There is a paradigm shift in breast biopsy philosophy. In

More information

Diseases of the breast (1 of 2)

Diseases of the breast (1 of 2) Diseases of the breast (1 of 2) Introduction A histology introduction Normal ducts and lobules of the breast are lined by two layers of cells a layer of luminal cells overlying a second layer of myoepithelial

More information

ER-P Expression in Different Thyroid Carcinomas: Immunohistochemical Study

ER-P Expression in Different Thyroid Carcinomas: Immunohistochemical Study Med. J. Cairo Univ., Vol. 85, No. 6, September: 5-9, 17 www.medicaljournalofcairouniversity.net ER-P Expression in Different Thyroid Carcinomas: Immunohistochemical Study MIRAN A. EL-KORDY, M.Sc.; FAHIMA

More information

CPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.

CPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. CPC 4 Breast Cancer Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. 1. What are the most likely diagnoses of this lump? Fibroadenoma

More information

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.

More information

04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES

04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES Pathology Perspectives of High Risk Breast Lesions Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head Director of Clinical Trials, Research and Development The University of Texas MD

More information

Immunohistochemical classification of breast tumours

Immunohistochemical classification of breast tumours Immunohistochemical classification of breast tumours Workshop in Diagnostic Immunohistochemistry September 19 th - 21 th 2018 Anne-Vibeke Lænkholm Department of Surgical Pathology, Zealand University Hospital,

More information

Evaluation the Correlation between Ki67 and 5 Years Disease Free Survival of Breast Cancer Patients

Evaluation the Correlation between Ki67 and 5 Years Disease Free Survival of Breast Cancer Patients BIOSCIENCES BIOTECHNOLOGY RESEARCH ASIA, December 2015. Vol. 12(3), 2221-2225 Evaluation the Correlation between Ki67 and 5 Years Disease Free Survival of Breast Cancer Patients S.M. Hosseini¹, H. Shahbaziyan

More information

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer Concepts in Prostate Pathology Murali Varma Cardiff, UK wptmv@cf.ac.uk Sarajevo Nov 2013 Outline (1) Peculiarities of prostate cancer Peculiarities of prostate needle biopsy Needle bx vs. TURP Prostate

More information

HISTOMORPHOLOGICAL SPECTRUM OF BREAST LESIONS

HISTOMORPHOLOGICAL SPECTRUM OF BREAST LESIONS HISTOMORPHOLOGICAL SPECTRUM OF BREAST LESIONS Kiran H. S, Jayaprakash Shetty, Chandrika Rao Assistant Professor, Department of Pathology, Yenepoya Medical College, Mangalore. Professor, Department of Pathology,

More information

Mammary Nodular Hyperplasia in Intact R hesus Monkeys

Mammary Nodular Hyperplasia in Intact R hesus Monkeys Vet. Path. 10: 130-134 (1973) Mammary Nodular Hyperplasia in Intact R hesus Monkeys L. W NELSON and L. D. SHOTT Department of Pathology and Toxicology, Mead Johnson Research Center, Evansville, Ind., and

More information

Pathology Report Patient Companion Guide

Pathology Report Patient Companion Guide Pathology Report Patient Companion Guide Breast Cancer - Understanding Your Pathology Report Pathology Reports can be overwhelming. They contain scientific terms that are unfamiliar and might be a bit

More information

Triple Negative Breast Cancer

Triple Negative Breast Cancer Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional

More information

Correlation Between GATA-3, Ki67 and p53 Expressions to Histopathology Grading of Breast Cancer in Makassar, Indonesia

Correlation Between GATA-3, Ki67 and p53 Expressions to Histopathology Grading of Breast Cancer in Makassar, Indonesia Cancer Research Journal 2016; 4(3): 43-47 http://www.sciencepublishinggroup.com/j/crj doi: 10.11648/j.crj.20160403.11 ISSN: 2330-8192 (Print); ISSN: 2330-8214 (Online) Correlation Between GATA-3, Ki67

More information

Presented by: Lillian Erdahl, MD

Presented by: Lillian Erdahl, MD Presented by: Lillian Erdahl, MD Learning Objectives What is Breast Cancer Types of Breast Cancer Risk Factors Warning Signs Diagnosis Treatment Options Prognosis What is Breast Cancer? A disease that

More information

Enterprise Interest None

Enterprise Interest None Enterprise Interest None B3 lesions of the breast What are they at surgery? Case 4 Edi Brogi MD PhD Attending Pathologist - Director of Breast Pathology Memorial Sloan Kettering Cancer Center New York

More information

Salivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches

Salivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches Salivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches Christopher C. Griffith, MD, PhD Raja R. Seethala, MD 1. Salivary gland tumor cytology: A

More information

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated

More information

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved. 1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of

More information

Histological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis

Histological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological Type

More information

Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma

Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department

More information

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer P A T H O L O G Y HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer FROM CERTAINTY COMES TRUST For in vitro diagnostic use HER2 CISH pharmdx Kit HER2 CISH pharmdx Kit is intended for dual-color

More information

Update in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016

Update in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish

More information

CD10 expression in stromal component of invasive breast carcinoma: A potential prognostic determinant

CD10 expression in stromal component of invasive breast carcinoma: A potential prognostic determinant Original article CD10 expression in stromal component of invasive breast carcinoma: A potential prognostic determinant Fereshteh Mohammadizadeh 1, Majid Salavati 2, Noushin Afshar Moghaddam 1 1 2 Associate

More information

Salivary Glands 3/7/2017

Salivary Glands 3/7/2017 Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.

More information

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers 29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar

More information

Recent advances in breast cancers

Recent advances in breast cancers Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response

More information

INTRA-OPERATIVE CYTOLOGY AND FROZEN SECTIONS OF BREAST LESIONS: A COMPARISON FROM A SAUDI TEACHING HOSPITAL

INTRA-OPERATIVE CYTOLOGY AND FROZEN SECTIONS OF BREAST LESIONS: A COMPARISON FROM A SAUDI TEACHING HOSPITAL Bahrain Medical Bulletin, Volume 18, Number 1, March 1996 INTRA-OPERATIVE CYTOLOGY AND FROZEN SECTIONS OF BREAST LESIONS: A COMPARISON FROM A SAUDI TEACHING HOSPITAL Ammar C.Al-Rikabi, MD,MRCPath,FIAC*

More information

Pathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY

Pathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY Pathology of Lobular & Ductal Preneoplasia Syed A Hoda, MD Weill-Cornell, New York, NY Proliferative Epithelial Changes in Breast A wide range of proliferative epithelial changes occur in the breast There

More information

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification

More information

Oncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II

Oncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital SALIVARY GLAND FNA: PART II Oncocytic,

More information

Flat Epithelial Atypia

Flat Epithelial Atypia Flat Epithelial Atypia Richard Owings, M.D. University of Arkansas for Medical Sciences Department of Pathology Flat epithelial atypia can be a difficult lesion May be a subtle diagnosis Lots of changes

More information

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5

More information

Breast Cancer Diagnosis, Treatment and Follow-up

Breast Cancer Diagnosis, Treatment and Follow-up Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce

More information

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research NCCN/JCCNB Seminar in Japan April 15, 2012 Case study 1 Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research Present illness: A 50y.o.premenopausal

More information

The Expression of Basal Cytokeratins in Breast Cancers

The Expression of Basal Cytokeratins in Breast Cancers Global Journal of Medical Research: C Microbiology and Pathology Volume 17 Issue 2 Version 1.0 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online

More information

ALAEZI CM 1 *, ADISA JO 2, OKOROCHI EC 3 and OKECHI OO 4

ALAEZI CM 1 *, ADISA JO 2, OKOROCHI EC 3 and OKECHI OO 4 Global Journal of Scientific Researches Available online at gjsr.blue-ap.org 2014 GJSR Journal. Vol. 2(2), pp. 51-55, 28 February, 2014 E-ISSN: 2311-732X METHYL GREEN PYRONIN: A PROGRESSIVE NUCLEAR STAIN

More information

Quality Assurance and Quality Control in the Pathology Dept.

Quality Assurance and Quality Control in the Pathology Dept. Quality Assurance and Quality Control in the Pathology Dept. Judith Sandbank M.D. Pathology Assaf-Harofeh Medical Center ISRAEL jsandbank@asaf.health.gov.il 2 nd IBDC, 9 th February, 2012 Pathology as

More information

Detection of Anaplastic Lymphoma Kinase (ALK) gene in Non-Small Cell lung Cancer (NSCLC) By CISH Technique

Detection of Anaplastic Lymphoma Kinase (ALK) gene in Non-Small Cell lung Cancer (NSCLC) By CISH Technique Cancer and Clinical Oncology; Vol. 7, No. 1; 2018 ISSN 1927-4858 E-ISSN 1927-4866 Published by Canadian Center of Science and Education Detection of Anaplastic Lymphoma Kinase (ALK) gene in Non-Small Cell

More information

High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.

High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei

More information

Disclosure of Relevant Financial Relationships. Breast Pathology Evening Specialty Conference Case #4. Clinical Case: Pathologic Features

Disclosure of Relevant Financial Relationships. Breast Pathology Evening Specialty Conference Case #4. Clinical Case: Pathologic Features Breast Pathology Evening Specialty Conference Case #4 K.P. Siziopikou, MD, PhD Professor of Pathology Director of Breast Pathology and Breast Pathology Fellowship Program Northwestern University Feinberg

More information

Comparison of CD10 expression in stroma of epithelial and mesenchymal tumors of the breast

Comparison of CD10 expression in stroma of epithelial and mesenchymal tumors of the breast Global Advanced Research Journal of Medicine and Medical Science (ISSN: 2315-5159) Vol. 4(1) pp. 051-056, January, 2015 Available online http://garj.org/garjmms/index.htm Copyright 2015 Global Advanced

More information

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein. 1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological

More information

Clinical pathological and epidemiological study of triple negative breast cancer

Clinical pathological and epidemiological study of triple negative breast cancer International Journal of Research in Medical Sciences Ajay A et al. Int J Res Med Sci. 217 Jun;5(6):2657-2661 www.msjonline.org pissn 232-71 eissn 232-12 Original Research Article DOI: http://dx.doi.org/1.1823/232-12.ijrms2172465

More information

Benign, Reactive and Inflammatory Lesions of the Breast

Benign, Reactive and Inflammatory Lesions of the Breast Benign, Reactive and Inflammatory Lesions of the Breast Marilin Rosa, MD Associate Member Section Head of Breast Pathology Department of Anatomic Pathology Program Director, Breast Pathology Fellowship

More information

International Society of Gynecological Pathologists Symposium 2007

International Society of Gynecological Pathologists Symposium 2007 International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade

More information

CODING TUMOUR MORPHOLOGY. Otto Visser

CODING TUMOUR MORPHOLOGY. Otto Visser CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show

More information

Barriers to Understanding

Barriers to Understanding Behind the Scenes: The Critical Importance of Cancer Cell Pathology and the Pathologist Sherry T. Emery, M.D., Chief of Pathology Northeast Health System Barriers to Understanding Questions for 2010 What

More information

Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience

Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Curzon M, Curzon C, Heidel RE, Desai P, McLoughlin J, Panella T, Bell

More information

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival

More information

Multiple Primary and Histology Site Specific Coding Rules BREAST. FLORIDA CANCER DATA SYSTEM MPH Breast Site Specific Coding Rules

Multiple Primary and Histology Site Specific Coding Rules BREAST. FLORIDA CANCER DATA SYSTEM MPH Breast Site Specific Coding Rules Multiple Primary and Histology Site Specific Coding Rules BREAST 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology

More information

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Medical Director, UF Health Breast Center Chief of Pathology

More information

Final Project Report Sean Fischer CS229 Introduction

Final Project Report Sean Fischer CS229 Introduction Introduction The field of pathology is concerned with identifying and understanding the biological causes and effects of disease through the study of morphological, cellular, and molecular features in

More information

Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women

Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women Journal of Bangladesh College of Physicians and Surgeons Vol. 28, No. 3, September 2010 Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women

More information

Clinical utility of cancer biomarkers assessed by virtual microscopy

Clinical utility of cancer biomarkers assessed by virtual microscopy Clinical utility of cancer biomarkers assessed by virtual microscopy Lina Seiz Clinical Research Unit Head: Prof. Dr. Manfred Schmitt Department of Obstetrics and Gynecology Klinikum rechts der Isar Established

More information

# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer

# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer #1034 - Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer Richard W. Cartun, MS, PhD Andrew Ricci, Jr, MD Department of Pathology Hartford

More information

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin Applications of IHC Determination of the primary site in metastatic tumors of unknown origin Classification of tumors that appear 'undifferentiated' by standard light microscopy Precise classification

More information

Jordan University Faculty Of Medicine. Breast. Dr. Ahmed Salman. Assistant professor of anatomy & embryology

Jordan University Faculty Of Medicine. Breast. Dr. Ahmed Salman. Assistant professor of anatomy & embryology Jordan University Faculty Of Medicine Breast Dr. Ahmed Salman Assistant professor of anatomy & embryology The breasts are specialized accessory glands of the skin that secretes milk. They are situated

More information

Papillary Lesions of the Breast

Papillary Lesions of the Breast Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School

More information

Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast

Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast ROBERT BARNES, M.D. AND SHAHLA MASOOD, M.D. The estrogen receptor (ER) expression of invasive breast cancer has been extensively

More information

DOCTORAL THESIS SUMMARY

DOCTORAL THESIS SUMMARY UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA FACULTY OF MEDICINE DOCTORAL THESIS SUMMARY CLINICO-IMAGING STUDY OF INVASIVE DUCTAL BREAST CARCINOMAS CORRELATED TO HORMONAL RECEPTORS AND HER2/NEU ONCOPROTEIN

More information

LOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN

LOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN LOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN Mirette Hanna MD Clinical pathology PhD (candidate) Experimental medicine MSc Clinical and chemical

More information

Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up

Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up DOI:http://dx.doi.org/10.7314/APJCP.2015.16.12.4921 Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up RESEARCH ARTICLE Properties of Synchronous Versus Metachronous

More information

Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value

Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value Shen Wei 1,a, Chen Juan 2, Li Xiurong 1 and Yin Jie 1 1 Department of Obstetrics and Gynecology,

More information

Table of contents. Page 2 of 40

Table of contents. Page 2 of 40 Page 1 of 40 Table of contents Introduction... 4 1. Background Information... 6 1a: Referral source for the New Zealand episodes... 6 1b. Invasive and DCIS episodes by referral source... 7 1d. Age of the

More information

Low-Grade Periductal Stromal of Breast: a case report

Low-Grade Periductal Stromal of Breast: a case report Low-Grade Periductal Stromal of Breast: a case report Rosanna Nenna 1 Cosimo Damiano Inchingolo 1 Domenico Palmieri 2 Annalisa De Lucia 1 Giusy Elicio 1 Pina Miscioscia 1 ( 1 ) U.O.C. di Anatomia Patologica,

More information

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC # DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #2006-01 CATEGORY: CLARIFICATION SUBJECT: RESCINDMENT - DSQC MEMORANDUM 2002-08 Coding Complex Morphologic Diagnoses (revised 8/02) EFFECTIVE: For Cases

More information

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers 日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu

More information

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA & IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA Suada Kuskunović*, Svjetlana Radović, Mirsad Dorić, Ajna Hukić, Mirsad Babić, Ivana Tomić,

More information

Cellular Dyscohesion in Fine-Needle Aspiration of Breast Carcinoma Prognostic Indicator for Axillary Lymph Node Metastases?

Cellular Dyscohesion in Fine-Needle Aspiration of Breast Carcinoma Prognostic Indicator for Axillary Lymph Node Metastases? natomic Pathology / PROGNOSTIC INDICTOR FOR XILLRY LYMPH NODE METSTSES Cellular Dyscohesion in Fine-Needle spiration of reast Carcinoma Prognostic Indicator for xillary Lymph Node Metastases? nne. Schiller,

More information

Surgical Pathology Issues of Practical Importance

Surgical Pathology Issues of Practical Importance Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast

More information

HISTOPATHOLOGICAL EVALUATION OF BENIGN PROLIFERATIVE BREAST LESIONS

HISTOPATHOLOGICAL EVALUATION OF BENIGN PROLIFERATIVE BREAST LESIONS 7 ORIGINAL ARTICLE HISTOPATHOLOGICAL EVALUATION OF BENIGN PROLIFERATIVE BREAST LESIONS DR. VIBHUTI H. CHIHLA*, DR. N N. JAGRIT **, DR. JAYASHREE M. SHAH*** *3 rd year Pathology Resident, **Associate Professor,

More information

Dr. Heba Kalbouneh. Dr. Heba Kalbouneh. Dr. Heba Kalbouneh

Dr. Heba Kalbouneh. Dr. Heba Kalbouneh. Dr. Heba Kalbouneh Dr. Heba Kalbouneh Dr. Heba Kalbouneh Dr. Heba Kalbouneh Basement membrane: What is the basement membrane? - It is a layer of ECM separating the epithelial cells from the underlying connective tissue Basement

More information

Mammary analogue secretory carcinoma of salivary gland A case report of new entity

Mammary analogue secretory carcinoma of salivary gland A case report of new entity Case Report Mammary analogue secretory carcinoma of salivary gland A case report of new entity Vaibhav Bhika Bari 1*, Sandhya Unmesh Bholay 2 1 Assistant Professor, 2 Associate Professor Rajiv Gandhi Medical

More information

Synchronous squamous cell carcinoma of the breast. and invasive lobular carcinoma

Synchronous squamous cell carcinoma of the breast. and invasive lobular carcinoma Sentani K et al. 1 Letter to the editor Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma Kazuhiro Sentani, 1 Takashi Tashiro, 2 Naohide Oue, 1 Wataru Yasui 1 1 Department

More information

Columnar Cell Lesions

Columnar Cell Lesions Columnar Cell Lesions Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Question? Columnar cell lesions are: a) Annoying lesions

More information

Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters

Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters & 2004 USCAP, Inc All rights reserved 0893-3952/04 $25.00 www.modernpathology.org Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical

More information

S100 protein expression in pituitary adenomas

S100 protein expression in pituitary adenomas S100 protein expression in pituitary adenomas Eugen MELnIc Department of Morphopathology, Nicolae Testemitsanu State University of Medicine and Pharmacy Chisinau, the Republic of Moldova Corresponding

More information

Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma

Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma Hadia. Mohammed. Abdalla. Abdalrhman *, Elsadig.A.Adam, Ayda.D.A.Allatif 3,'Namareg.E.Afadul

More information

ACRIN 6666 Therapeutic Surgery Form

ACRIN 6666 Therapeutic Surgery Form S1 ACRIN 6666 Therapeutic Surgery Form 6666 Instructions: Complete a separate S1 form for each separate area of each breast excised with the intent to treat a cancer (e.g. each lumpectomy or mastectomy).

More information

Overview of breast cancerpatients and their prognostic factors treated in Baghdad teaching hospital/ oncology department in the year 2010

Overview of breast cancerpatients and their prognostic factors treated in Baghdad teaching hospital/ oncology department in the year 2010 Original Article Overview of breast cancerpatients and their prognostic factors treated in Baghdad teaching hospital/ oncology department in the year 21 * DMRT clinical oncology, MSc. pathology. Summary:

More information

Objectives. Salivary Gland FNA: The Milan System. Role of Salivary Gland FNA 04/26/2018

Objectives. Salivary Gland FNA: The Milan System. Role of Salivary Gland FNA 04/26/2018 Salivary Gland FNA: The Milan System Dr. Jennifer Brainard Section Head Cytopathology Cleveland Clinic Objectives Introduce the Milan System for reporting salivary gland cytopathology Define cytologic

More information

Triple Negative Breast Cancer: Clinical Presentation and Multimodality Imaging Characteristics

Triple Negative Breast Cancer: Clinical Presentation and Multimodality Imaging Characteristics Triple Negative Breast Cancer: Clinical Presentation and Multimodality Imaging Characteristics Poster No.: R-0141 Congress: RANZCR-AOCR 2012 Type: Scientific Exhibit Authors: O. H. Woo, S. Jang, K. R.

More information